Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 3/20 | 0.56 |
| ▸ | ANPEP | P15144 | 2/20 | 0.47 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.47 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
| ▸ | GRM6 | O15303 | 1/20 | 0.46 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21616493 | 0.81 | L3MBTL1 (0.51) | ACP3ALDH1A1AOC3 | |
| SCHEMBL21616501 | 0.80 | CA12 (0.43) | ACP3TSHRCA1CA12 | |
| SCHEMBL21616497 | 0.78 | HTR2A (0.47) | ACP3CA12MMP2CA9CA14 | |
| SCHEMBL21616509 | 0.77 | GABBR2 (0.46) | ACP3CA12MMP2 | |
| SCHEMBL21616488 | 0.77 | LMNA (0.64) | ACP3TSHRMMP2 | |
| SCHEMBL28846652 | 0.76 | ACP3 (0.56) | ACP3ANPEPERAP2GRM8GRM6 | |
| SCHEMBL2960575 | 0.76 | ACP3 (0.63) | ACP3ANPEP | |
| SCHEMBL5746245 | 0.74 | ACP3 (0.62) | ACP3GRM8GRM6GRM4ALDH1A1 | |
| SCHEMBL5745970 | 0.74 | ACP3 (0.62) | ACP3GRM8GRM6GRM4ALDH1A1 | |
| SCHEMBL11087848 | 0.74 | ACP3 (0.62) | ACP3GRM8GRM6GRM4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11401288-B2 | Beta-amino phosphonic acid derivative and preparation method therefor | SOOCHOW UNIVERSITY (CN) | 2022-08-02 | — | — | US | disclosed |
| US-20210130376-A1 | BETA-AMINO PHOSPHONIC ACID DERIVATIVE AND PREPARATION METHOD THEREFOR | SOOCHOW UNIVERSITY (CN) | 2021-05-06 | — | — | US | disclosed |
| CN-108727428-B | β -aminophosphonic acid derivatives and process for their preparation | 苏州大学 | 2020-05-08 | — | — | CN | disclosed |
| WO-2020010586-A1 | β-AMINO PHOSPHONIC ACID DERIVATIVE AND PREPARATION METHOD THEREFOR | 苏州大学张家港工业技术研究院 | 2020-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130376-A1 | BETA-AMINO PHOSPHONIC ACID DERIVATIVE AND PREPARATION METHOD THEREFOR | AADAT, PHYKPL, AASDHPPT | ACP3 1006/4885ANPEP 24/4885ERAP2 1324/4885 |
| US-11401288-B2 | Beta-amino phosphonic acid derivative and preparation method therefor | AADAT, PHYKPL, AASDHPPT | ACP3 1006/4885ANPEP 24/4885ERAP2 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.